In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.
Robert F. Kennedy Jr. spent 2 days this week insisting to senators that he's not anti-vaccine. He said that he instead supports vaccinations and will follow the science in overseeing the $1.7 trillion ...